Table 1.
Vaccinated (n = 109) | Non-Vaccinated (n = 92) | p-Value | |
---|---|---|---|
Female (n, %) | 67 (61.5%) | 43 (46.75%) | 0.159 |
Age (years) * | 65.0 ± 21.0 | 46.5 ± 16.0 | <0.001 |
Weight (kg) | 77.7 ± 13.5 | 76.6 ± 13.9 | 0.557 |
Height (cm) | 164.8 ± 8.6 | 167.5 ± 9.2 | 0.304 |
Previous Medical Co-morbidities | |||
Number of pre-existing co-morbidities * | 1.7 ± 1.0 | 0.85 ± 0.95 | <0.001 |
Obesity (pre-existing) | 33 (30.3%) | 20 (21.7%) | 0.240 |
Hypertension (pre-existing) | 51 (46.8%) | 21 (22.8%) | 0.318 |
Diabetes (pre-existing) | 23 (21.1%) | 5 (5.4%) | 0.212 |
Asthma (pre-existing) | 12 (11.0%) | 7 (7.6%) | 0.434 |
COPD (pre-existing) * | 10 (9.2%) | 2 (2.2%) | 0.04 |
Pain (pre-existing) * | 51 (46.8%) | 26 (28.25%) | 0.03 |
Cardiac diseases (pre-existing) * | 21 (19.3%) | 6 (6.5%) | 0.01 |
Rheumatological diseases (pre-existing) * | 29 (26.6%) | 6 (6.5%) | <0.001 |
Other diseases (pre-existing) | 22 (20.2%) | 13 (14.1%) | 0.305 |
COVID-19 associated-onset symptoms at hospital admission | |||
Number of COVID-19 symptoms | 2.4 ± 0.9 | 2.65 ± 0.65 | 0.677 |
Fever (COVID-19 onset) | 70 (64.2%) | 60 (65.2%) | 0.930 |
Dyspnea (COVID-19 onset) | 22 (20.2%) | 27 (29.35%) | 0.189 |
Myalgias (COVID-19 onset) | 39 (35.8%) | 29 (31.5%) | 0.605 |
Cough (COVID-19 onset) | 37 (33.9%) | 30 (32.6%) | 0.870 |
Headache (COVID-19 onset) | 40 (36.7%) | 26 (28.25%) | 0.298 |
Diarrhea (COVID-19 onset) | 4 (3.7%) | 13 (14.1%) | 0.708 |
Anosmia (COVID-19 onset) | 15 (13.8%) | 14 (15.2%) | 0.786 |
Ageusia (COVID-19 onset) * | 11 (10.1%) | 21 (22.8%) | 0.02 |
Throat pain (COVID-19 onset) | 15 (13.8%) | 17 (18.5%) | 0.404 |
Vomiting (COVID-19 onset) | 1 (0.9%) | 2 (2.2%) | 0.467 |
Dizziness (COVID-19 onset) | 5 (4.6%) | 6 (6.5%) | 0.559 |
Days at hospital * | 12.9 ± 12.45 | 9.7 ± 7.8 | 0.03 |
ICU admission | 11 (10.1%) | 8 (8.7%) | 0.748 |
* Significant differences between vaccinated and non-vaccinated groups (p < 0.05).